SCHEMBL2020493

SCHEMBL2020493

c1cncc(-c2cccc(-c3ccc4c5ccc(-c6cccc(-c7cccnc7)n6)cc5c5ccccc5c4c3)n2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 3/20 0.56
CYP2A6 P11509 3/20 0.54
CYP11B1 P15538 2/20 0.53
CYP17A1 P05093 1/20 0.47
CYP11B2 P19099 1/20 0.47
DHODH Q02127 1/20 0.47
NPC1 O15118 2/20 0.46
HSP90AA1 P07900 1/20 0.45
HSP90AB1 P08238 1/20 0.45
PTK2 Q05397 1/20 0.45
MAPT P10636 1/20 0.44
KMO O15229 1/20 0.44
CYP1A2 P05177 3/20 0.44
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.44
CYP3A4 P08684 2/20 0.44
KMT2A Q03164 2/20 0.44
KARS1 Q15046 1/20 0.44
LMNA P02545 1/20 0.44
HTT P42858 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19222809 1.00 CYP19A1 (0.56) CYP19A1CYP2A6CYP11B1CYP17A1CYP11B2
SCHEMBL15459447 0.98 CYP19A1 (0.54) CYP19A1CYP2A6CYP11B1CYP17A1CYP11B2
SCHEMBL15459439 0.97 CYP2A6 (0.57) CYP19A1CYP2A6CYP11B1CYP17A1CYP11B2
SCHEMBL24492905 0.95 CYP19A1 (0.55) CYP19A1CYP2A6CYP11B1CYP17A1CYP11B2
SCHEMBL23843492 0.93 CYP19A1 (0.56) CYP19A1CYP2A6CYP11B1CYP17A1CYP11B2
SCHEMBL15459433 0.92 CYP2A6 (0.58) CYP19A1CYP2A6CYP11B1CYP17A1CYP11B2
SCHEMBL9973758 0.90 CYP2A6 (0.49) CYP19A1CYP2A6CYP11B1CYP17A1CYP11B2
SCHEMBL9973763 0.90 CYP19A1 (0.50) CYP19A1CYP2A6CYP11B1CYP17A1CYP11B2
SCHEMBL19767982 0.88 CYP11B1 (0.50) CYP19A1CYP2A6CYP11B1CYP17A1CYP11B2
SCHEMBL16904490 0.88 CYP19A1 (0.66) CYP19A1CYP2A6CYP11B1CYP17A1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10797242-B2 Compound having substituted triphenylene ring structure, and organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2020-10-06 US disclosed
US-10026903-B2 Compound having substituted triphenylene ring structure, and organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2018-07-17 US disclosed
US-10026903-B2 Compound having substituted triphenylene ring structure, and organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2018-07-17 US disclosed
US-20170338417-A1 COMPOUND HAVING SUBSTITUTED TRIPHENYLENE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO LTD (JP) 2017-11-23 US disclosed
US-20170338417-A1 COMPOUND HAVING SUBSTITUTED TRIPHENYLENE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO LTD (JP) 2017-11-23 US disclosed
US-20170271595-A1 COMPOUND HAVING SUBSTITUTED TRIPHENYLENE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO LTD (JP) 2017-09-21 US disclosed
US-20170271595-A1 COMPOUND HAVING SUBSTITUTED TRIPHENYLENE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO LTD (JP) 2017-09-21 US disclosed
EP-2679581-B1 COMPOUND CONTAINING SUBSTITUTED TRIPHENYLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT ELEMENT HODOGAYA CHEMICAL CO LTD (JP) 2017-08-09 EP disclosed
US-9685612-B2 Compound having substituted triphenylene ring structure, and organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2017-06-20 US disclosed
US-9685612-B2 Compound having substituted triphenylene ring structure, and organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2017-06-20 US disclosed
US-8202633-B2 Electron transport material and organic electroluminescent device using the same JNC CORPORATION (JP) 2012-06-19 US disclosed
US-20110215310-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME SK MATERIALS JNC CO., LTD. (KR) 2011-09-08 US disclosed
US-20110215310-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME SK MATERIALS JNC CO., LTD. (KR) 2011-09-08 US disclosed
US-20110215310-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME SK MATERIALS JNC CO., LTD. (KR) 2011-09-08 US disclosed
US-7964293-B2 Electron transport material and organic electroluminescent device using the same JNC CORPORATION (JP) 2011-06-21 US disclosed
US-7964293-B2 Electron transport material and organic electroluminescent device using the same JNC CORPORATION (JP) 2011-06-21 US disclosed
US-7964293-B2 Electron transport material and organic electroluminescent device using the same JNC CORPORATION (JP) 2011-06-21 US disclosed
US-20090134780-A1 Electron transport material and organic electroluminescent device using the same SK MATERIALS JNC CO., LTD. (KR) 2009-05-28 US disclosed
US-20090134780-A1 Electron transport material and organic electroluminescent device using the same SK MATERIALS JNC CO., LTD. (KR) 2009-05-28 US disclosed
US-20090134780-A1 Electron transport material and organic electroluminescent device using the same SK MATERIALS JNC CO., LTD. (KR) 2009-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110215310-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME SLC25A11, ELAVL1, SLC26A3 CYP19A1 3499/4885CYP2A6 4405/4885CYP11B1 1482/4885
US-10797242-B2 Compound having substituted triphenylene ring structure, and organic electroluminescent device DCX, SLC25A21, SLC19A2 CYP19A1 919/4885CYP2A6 3206/4885CYP11B1 506/4885
US-20170338417-A1 COMPOUND HAVING SUBSTITUTED TRIPHENYLENE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE DCX, SLC25A21, SLC19A2 CYP19A1 919/4885CYP2A6 3206/4885CYP11B1 506/4885
US-10026903-B2 Compound having substituted triphenylene ring structure, and organic electroluminescent device DCX, SLC25A21, SLC19A2 CYP19A1 919/4885CYP2A6 3206/4885CYP11B1 506/4885
US-20090134780-A1 Electron transport material and organic electroluminescent device using the same SLC25A11, ELAVL1, SLC26A3 CYP19A1 3499/4885CYP2A6 4405/4885CYP11B1 1482/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.